Charlie Schmidt. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » AnimalsAntineoplastic Agents/pharmacologyAutoimmunityCarcinoma, Non-Small-Cell Lung/immunologyCarcinoma, Non-Small-Cell Lung/therapyCarcinoma, Renal Cell/immunologyCarcinoma, Renal Cell/therapyHumansInflammation/immunologyKidney Neoplasms/immunologyKidney Neoplasms/therapyLipopolysaccharides/metabolismLung Neoplasms/immunologyLung Neoplasms/therapyNeoplasms/immunologyNeoplasms/therapySepsis/immunologyTh1 Cells/immunologyTh2 Cells/immunologyToll-Like Receptor 7/drug effectsToll-Like Receptor 9/drug effectsToll-Like Receptors/agonistsToll-Like Receptors/antagonists & inhibitorsToll-Like Receptors/drug effects
Substances: See more » Antineoplastic AgentsLipopolysaccharidesToll-Like Receptor 7Toll-Like Receptor 9Toll-Like Receptors
Year: 2006 PMID: 16670380 DOI: 10.1093/jnci/djj198
Source DB: PubMed Journal: J Natl Cancer Inst ISSN: 0027-8874 Impact factor: 13.506